UC Merced biology Professor Rudy Ortiz is furthering his innovative research into diabetes with support from a major pharmaceutical company.
Ortiz' work, developing new applications for medicines used to treat the effects of insulin resistance, has been funded by Amylin Pharmaceuticals LLC, a...